Breadcrumbs
Home / AL: Jury Orders Drug Firm to Pay $215 Million; Firm Says It Will AppealAL: Jury Orders Drug Firm to Pay $215 Million; Firm Says It Will Appeal
Last Updated on Friday, 22 February 2008 11:53 Written by rslcpol Friday, 22 February 2008 11:53
MONTGOMERY – A state court jury awarded Alabama $215 million Thursday in its Medicaid drug price fraud suit against AstraZeneca Pharmaceuticals LP.
The circuit court jury said the subsidiary of Britain’s AstraZeneca PLC must pay $40 million in compensatory damages and $175 million in punitive damages.
“A grave misjustice has been righted,” Alabama Attorney General Troy King said after hearing the verdict.
Judge Charles Price indicated he would go along with the jury’s judgment.
A spokesman for AstraZeneca said the company would appeal the verdict to the Alabama Supreme Court.